| scholarly article | Q13442814 |
| P2093 | author name string | Sung-Hoon Kim | |
| Hyun Jung Kim | |||
| Jae-Hoon Kim | |||
| Ahwon Lee | |||
| In Ho Lee | |||
| Dae-Yeon Kim | |||
| Sokbom Kang | |||
| Woong Ju | |||
| Jin Hwa Hong | |||
| Taek Sang Lee | |||
| Tae-Jin Kim | |||
| Hee-Sug Ryu | |||
| Suk-Joon Chang | |||
| Myong Cheol Lim | |||
| Hee Jae Joo | |||
| Hyeong Sik Ahn | |||
| Yonghee Lee | |||
| Byoung-Gie Kim | |||
| Yong-Man Kim | |||
| Chong Woo Yoo | |||
| Hye-Kyoung Yoon | |||
| Sung-Ran Hong | |||
| Hye Sun Kim | |||
| Jeong-Won Lee | |||
| Keun-Ho Lee | |||
| Soo-Young Hur | |||
| Jae Yun Song | |||
| Hyun Hoon Chung | |||
| Jae Kwan Lee | |||
| Jae-Weon Kim | |||
| Joo-Hyun Nam | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| What is "quality of evidence" and why is it important to clinicians? | Q24647929 | ||
| Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial | Q24679201 | ||
| Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening | Q24684588 | ||
| 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ | Q28251233 | ||
| Cytologic-histologic correlation of screening and diagnostic Papanicolaou tests | Q30440782 | ||
| Atypical glandular cells of undetermined significance: a five-year retrospective histopathologic study | Q30472553 | ||
| POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women | Q30917882 | ||
| HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial | Q31044179 | ||
| Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial | Q31151637 | ||
| Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening | Q44876752 | ||
| A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations | Q45028763 | ||
| Cervical dysplasia in pregnancy: a multi-institutional evaluation | Q45155631 | ||
| Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation | Q46040726 | ||
| Direct comparison of liquid-based and conventional cytology in a South African screening trial | Q46259100 | ||
| The ATHENA human papillomavirus study: design, methods, and baseline results | Q46401520 | ||
| Diagnoses and outcomes in cervical cancer screening: a population-based study. | Q50747235 | ||
| Natural history of cervicovaginal papillomavirus infection in young women. | Q50909200 | ||
| Effective cervical neoplasia detection with a novel optical detection system: a randomized trial. | Q51093419 | ||
| Clinical performance assessment of five human papillomavirus DNA tests using liquid-based cytology samples. | Q51543570 | ||
| Evaluation of a liquid bead array system for high-risk human papillomavirus detection and genotyping in comparison with Hybrid Capture II, DNA chip and sequencing methods | Q51553909 | ||
| Comparison of human papillomavirus detection and typing by hybrid capture 2, linear array, DNA chip, and cycle sequencing in cervical swab samples. | Q51566758 | ||
| HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. | Q51824401 | ||
| Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence. | Q51964812 | ||
| The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. | Q51968734 | ||
| Alternative technologies in cervical cancer screening: a randomised evaluation trial | Q33260497 | ||
| Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data | Q33488158 | ||
| Clinical usefulness of cervicogram as a primary screening test for cervical neoplasia | Q33659075 | ||
| Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection | Q33691649 | ||
| Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students | Q33963919 | ||
| Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral | Q34153160 | ||
| Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence | Q34176414 | ||
| Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance | Q34208644 | ||
| Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement | Q34282601 | ||
| Management of women who test positive for high-risk types of human papillomavirus: the HART study | Q34282635 | ||
| The promise of global cervical-cancer prevention | Q34468217 | ||
| Incidence, clearance and predictors of human papillomavirus infection in women. | Q34536772 | ||
| Human papillomavirus and Papanicolaou tests to screen for cervical cancer | Q34702284 | ||
| Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients | Q35138635 | ||
| Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme | Q35324720 | ||
| Current status of the National Cancer Screening Program for cervical cancer in Korea, 2009. | Q35758701 | ||
| Chapter 5: Updating the natural history of HPV and anogenital cancer | Q36584420 | ||
| The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women | Q36615291 | ||
| Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting | Q36615447 | ||
| Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women | Q36622396 | ||
| A "see and treat" management for high-grade squamous intraepithelial lesion pap smears | Q36628115 | ||
| Grading quality of evidence and strength of recommendations for diagnostic tests and strategies | Q36661809 | ||
| Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort | Q36695625 | ||
| HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. | Q36708180 | ||
| A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women | Q36980796 | ||
| The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings | Q37250812 | ||
| Comparison of the novel human papillomavirus 4 auto-capillary electrophoresis test with the hybrid capture 2 assay and with the PCR HPV typing set test in the detection of high-risk HPV including HPV 16 and 18 genotypes in cervical specimens | Q37284778 | ||
| The management of cervical intraepithelial neoplasia during pregnancy: is colposcopy necessary? | Q37528935 | ||
| Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial | Q37622656 | ||
| Cervical cancer: cytological cervical screening in Iceland and implications of HPV vaccines | Q37774399 | ||
| Human papillomavirus type distribution in women from Asia: a meta-analysis | Q40218340 | ||
| The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period | Q40276124 | ||
| Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results | Q41650820 | ||
| See-and-treat in the management of high-grade squamous intraepithelial lesions of the cervix: a resource utilization analysis | Q41688419 | ||
| Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST). | Q43500319 | ||
| Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study | Q43879082 | ||
| Follow-up of abnormal gynecologic cytology: a college of American pathologists Q-probes study of 16132 cases from 306 laboratories | Q44767732 | ||
| Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. | Q53028990 | ||
| Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. | Q53304855 | ||
| Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. | Q53322866 | ||
| Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease. | Q53346195 | ||
| Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. | Q53398008 | ||
| Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy? | Q53436711 | ||
| Type-specific human papillomavirus DNA detected in atypical glandular cell Pap tests. | Q54321341 | ||
| Cytology alone versus cytology and cervicography for cervical cancer screening: a randomized study | Q57415162 | ||
| Cervical cancer screening with cervicography and cytology | Q72257697 | ||
| Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women | Q73592427 | ||
| Cost-effectiveness of monolayers and human papillomavirus testing compared to that of conventional Papanicolaou smears for cervical cancer screening: protocol of the study of the French Society of Clinical Cytology | Q73970068 | ||
| Conservative management of cervical intraepithelial neoplasia (CIN(2-3)) in pregnant women | Q78883583 | ||
| Is it rational to start population-based cervical cancer screening at or soon after age 20? Analysis of time trends in preinvasive and invasive diseases | Q79607613 | ||
| Natural history of cervical intraepithelial neoplasia during pregnancy | Q79703204 | ||
| Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3 | Q80629732 | ||
| Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears | Q81101632 | ||
| The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment | Q81151757 | ||
| Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial | Q81404025 | ||
| Dysplasia associated with atypical glandular cells on cervical cytology | Q81454172 | ||
| Lack of adherence to practice guidelines for women with atypical glandular cells on cervical cytology | Q81454176 | ||
| Does the interval between papanicolaou tests influence the quality of cytology? | Q81635450 | ||
| A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy? | Q81713706 | ||
| Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial | Q82586477 | ||
| Cervical cancer screening | Q82835733 | ||
| Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial | Q83938901 | ||
| Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study | Q84818275 | ||
| ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening | Q84853922 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | cytopathology | Q1881849 |
| gynecologic oncology | Q5625186 | ||
| cervix uterine cancer | Q160105 | ||
| P304 | page(s) | 186-203 | |
| P577 | publication date | 2013-04-05 | |
| P1433 | published in | Journal of gynecologic oncology | Q26842232 |
| P1476 | title | Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition | |
| P478 | volume | 24 |
| Q38645123 | Atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion triage in Korean women: Revisiting the 2012 American Society of Colposcopy and Cervical Pathology screening guidelines |
| Q92995485 | Carcinogenic risk of human papillomavirus (HPV) genotypes and potential effects of HPV vaccines in Korea |
| Q28069711 | Cervical Cancer Screening after Perimenopause: How Is Human Papillomavirus Test Performed? |
| Q37133271 | Clinical Significance of an HPV DNA Chip Test with Emphasis on HPV-16 and/or HPV-18 Detection in Korean Gynecological Patients |
| Q42218921 | Clinical significance of HPV DNA cotesting in Korean women with ASCUS or ASC-H. |
| Q57213824 | Comparison of cervical cancer screening among women with and without hysterectomies: a nationwide population-based study in Korea |
| Q35808851 | Comparison of the Cobas 4800 HPV and HPV 9G DNA Chip Tests for Detection of High-Risk Human Papillomavirus in Cervical Specimens of Women with Consecutive Positive HPV Tests But Negative Pap Smears |
| Q53279056 | Long-term outcomes after fertility-sparing laparoscopic radical trachelectomy in young women with early-stage cervical cancer: an Asan Gynecologic Cancer Group (AGCG) study. |
| Q39313435 | Management of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years |
| Q55398396 | Proposal for cervical cancer screening in the era of HPV vaccination. |
| Q36064840 | Reflex Human Papillomavirus Test Results as an Option for the Management of Korean Women With Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion. |
| Q35876962 | The Korean guideline for cervical cancer screening |
| Q36008098 | The health beliefs of mothers about preventing cervical cancer and their intention to recommend the Pap test to their daughters: a cross-sectional survey |
| Q37022503 | Updates of the current screening guidelines for the early detection of cervical cancer |
Search more.